Previous close | 307.60 |
Open | 308.40 |
Bid | 313.10 x N/A |
Ask | 313.60 x N/A |
Day's range | 308.40 - 319.40 |
52-week range | 191.30 - 353.80 |
Volume | |
Avg. volume | 761,447 |
Market cap | 371.762B |
Beta (5Y monthly) | 1.23 |
PE ratio (TTM) | 238.18 |
EPS (TTM) | 1.32 |
Earnings date | 12 Jul 2024 - 16 Jul 2024 |
Forward dividend & yield | 3.60 (1.15%) |
Ex-dividend date | 29 Nov 2024 |
1y target est | 350.82 |
EQT is pleased to announce that the EQT Healthcare Growth Strategy and the EQT Growth Fund have agreed to acquire a majority stake in CluePoints (the "Company"), with meaningful reinvestment from the management team and existing shareholders Summit Partners and Clinimetrics SA, which was also a co-founder of the Company.
The total number of shares and votes in EQT AB (publ) ("EQT") has decreased by 3,923,000 shares and votes during May 2024 as a result of a cancellation of 3,923,000 ordinary shares held in treasury by EQT. The cancellation was resolved by the Annual Shareholders' Meeting 2024 on 27 May 2024, in line with EQT's intention to off-set over time the dilution impact from shares delivered to participants in EQT's Share and Option Programs.
EQT Exeter, a leading global real estate investment manager, today announced that the EQT Exeter Industrial Value Fund VI ("EQT Exeter") has acquired 20 industrial properties ("the Assemblage") strategically located in Minneapolis, MN, from Prologis, Inc. ("Prologis"), with plans to acquire an additional four properties by the final closing date.